JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Biochemical Reagent
Signaling pathways

Signaling pathways

BA2640 Gly3-VC-PAB-MMAE

Summary: Gly3-VC-PAB-MMAE consists of degradable (cleavable) (Gly3-VC-PAB) and MMAE, a potent microtubule (tubulin) inhibitor.
BA2641 MC-VA-PABC-MMAE

Summary: MC-VA-PABC-MMAE is part of an antibody-coupled active molecule.
BA2642 MC-betaglucuronide-MMAE-1

Summary: MC-betaglucuronide-MMAE-1 is part of.
BA2643 DM21

Summary: DM21 is a cleavable affix of an ADC active molecule and linker (ADClinker).
BA2645 Mal-PEG4-VC-PAB-DMEA-PNU-159682

Summary: Mal-PEG4-VC-PAB-DMEA-PNU-159682 is an active molecule-coupling consisting of the ADC connector Mal-PEG4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682.
BA2646 Amino-PEG4-Val-Cit-PAB-MMAE

Summary: Can be used to synthesize antibody-coupled reactive molecules (ADCs).
BA2647 DBCO-PEG4-Val-Cit-PAB-MMAF

Summary: DBCO-PEG4-Val-Cit-PAB-MMAF consists of degradable (cleavable) 4-unit PEG-containing (DBCO-PEG4-Val-Cit-PAB) and MMAF.
BA2648 Mal-PEG8-Val-Cit-PAB-MMAE

Summary: Mal-PEG8-Val-Cit-PAB-MMAE is part of the antibody-coupled active molecule ADC.
BA2649 DBCO-PEG4-VA-PBD

Summary: DBCO-PEG4-VA-PBD is an antibody-coupled active molecule consisting of the antitumor antibiotic Pyrrolobenzodiazepine (PBD) linked to DBCO-PEG4-VA.
BA2650 MAL-di-EG-Val-Cit-PAB-MMAE

Summary: It is composed of MonomethylE (MMAE), a highly potent microtubule inhibitor, coupled with the peptide linker MAL-di-EG-Val-Cit-PAB.